Funded Research

From the U.S. National Institutes of Health (NIH)

NIAID - BARDA

Inhalation of a dry-powder formulation of gentamicin (NanoGENT™), a broad spectrum antibiotic, targeted against two aerosolized Category A bioterrorism agents.

NIAID

Inhalation of dry-powder formulation of the antiviral drug cidofovir (NanoFOVIR™).

NIDA

Preclinical and clinical evaluation of oral fine particle formulation of buprenorphine (NanoBUP™) to treat opiate addiction. Goal is to provide slower and more uniform release of the drug that is currently in use.

NIAID

Evaluate the pharmacokinetics and absorption of an oral fine particle formulation of DTPA (NanoDTPA™) for chelation therapy.